ACER Annual CFI
-$171.20 K
-$116.30 K-211.84%
31 December 2022
Summary:
As of January 26, 2025, ACER annual cash flow from investing activities is -$171.20 thousand, with the most recent change of -$116.30 thousand (-211.84%) on December 31, 2022. During the last 3 years, it has risen by +$7800.00 (+4.36%).ACER Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACER Quarterly CFI
$0.00
+$3100.00+100.00%
30 June 2023
Summary:
As of January 26, 2025, ACER quarterly cash flow from investing activities is $0.00, with the most recent change of +$3100.00 (+100.00%) on June 30, 2023. Over the past year, it has increased by +$2000.00 (+100.00%).ACER Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACER TTM CFI
-$143.30 K
+$2000.00+1.38%
30 June 2023
Summary:
As of January 26, 2025, ACER TTM cash flow from investing activities is -$143.30 thousand, with the most recent change of +$2000.00 (+1.38%) on June 30, 2023. Over the past year, it has dropped by -$72.70 thousand (-102.97%).ACER TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACER Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -211.8% | +100.0% | -103.0% |
| 3 y3 years | +4.4% | 0.0% | -225.7% |
| 5 y5 years | -117.7% | +100.0% | +19.9% |
ACER Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -117.7% | -100.0% | -113.9% |
Acer Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $0.00(-100.0%) | -$143.30 K(-1.4%) |
| Mar 2023 | - | -$3100.00(-97.7%) | -$145.30 K(-15.1%) |
| Dec 2022 | -$171.20 K(+211.8%) | -$135.30 K(+2661.2%) | -$171.10 K(+203.9%) |
| Sept 2022 | - | -$4900.00(+145.0%) | -$56.30 K(-20.3%) |
| June 2022 | - | -$2000.00(-93.1%) | -$70.60 K(-10.1%) |
| Mar 2022 | - | -$28.90 K(+41.0%) | -$78.50 K(+43.0%) |
| Dec 2021 | -$54.90 K(+403.7%) | -$20.50 K(+6.8%) | -$54.90 K(+27.4%) |
| Sept 2021 | - | -$19.20 K(+93.9%) | -$43.10 K(+65.1%) |
| June 2021 | - | -$9900.00(+86.8%) | -$26.10 K(+61.1%) |
| Mar 2021 | - | -$5300.00(-39.1%) | -$16.20 K(+48.6%) |
| Dec 2020 | -$10.90 K(-93.9%) | -$8700.00(+295.5%) | -$10.90 K(-80.2%) |
| Sept 2020 | - | -$2200.00(<-9900.0%) | -$55.10 K(+25.2%) |
| June 2020 | - | $0.00(0.0%) | -$44.00 K(-51.1%) |
| Mar 2020 | - | $0.00(-100.0%) | -$90.00 K(-49.7%) |
| Dec 2019 | -$179.00 K(+87.2%) | -$52.90 K(-694.4%) | -$178.90 K(+30.9%) |
| Sept 2019 | - | $8900.00(-119.3%) | -$136.70 K(-36.5%) |
| June 2019 | - | -$46.00 K(-48.3%) | -$215.40 K(+23.2%) |
| Mar 2019 | - | -$88.90 K(+730.8%) | -$174.80 K(+82.7%) |
| Dec 2018 | -$95.60 K(-109.9%) | -$10.70 K(-84.7%) | -$95.70 K(-34.1%) |
| Sept 2018 | - | -$69.80 K(+1192.6%) | -$145.30 K(-116.1%) |
| June 2018 | - | -$5400.00(-44.9%) | $902.10 K(-0.6%) |
| Mar 2018 | - | -$9800.00(-83.7%) | $907.50 K(-6.2%) |
| Dec 2017 | $967.30 K(<-9900.0%) | -$60.30 K(-106.2%) | $967.30 K(-5.9%) |
| Sept 2017 | - | $977.60 K(>+9900.0%) | $1.03 M(+1955.2%) |
| June 2017 | - | $0.00(-100.0%) | $50.00 K(+1.4%) |
| Mar 2017 | - | $50.00 K(>+9900.0%) | $49.30 K(-4208.3%) |
| Dec 2016 | -$1200.00(-98.7%) | $0.00(0.0%) | -$1200.00(-94.9%) |
| Sept 2016 | - | $0.00(-100.0%) | -$23.60 K(-71.1%) |
| June 2016 | - | -$700.00(+40.0%) | -$81.80 K(-5.4%) |
| Mar 2016 | - | -$500.00(-97.8%) | -$86.50 K(-6.4%) |
| Dec 2015 | -$92.30 K(-51.7%) | -$22.40 K(-61.5%) | -$92.40 K(-17.3%) |
| Sept 2015 | - | -$58.20 K(+977.8%) | -$111.70 K(+47.9%) |
| June 2015 | - | -$5400.00(-15.6%) | -$75.50 K(-37.8%) |
| Mar 2015 | - | -$6400.00(-84.7%) | -$121.40 K(-36.4%) |
| Dec 2014 | -$190.90 K(-125.8%) | -$41.70 K(+89.5%) | -$190.90 K(-1.7%) |
| Sept 2014 | - | -$22.00 K(-57.1%) | -$194.20 K(-242.3%) |
| June 2014 | - | -$51.30 K(-32.4%) | $136.50 K(-18.5%) |
| Mar 2014 | - | -$75.90 K(+68.7%) | $167.50 K(-77.4%) |
| Dec 2013 | $740.80 K(-147.8%) | -$45.00 K(-114.6%) | $740.80 K(-0.9%) |
| Sept 2013 | - | $308.70 K(-1620.7%) | $747.50 K(-224.5%) |
| June 2013 | - | -$20.30 K(-104.1%) | -$600.20 K(-25.6%) |
| Mar 2013 | - | $497.40 K(-1398.7%) | -$807.10 K(-47.9%) |
| Dec 2012 | -$1.55 M(+422.2%) | -$38.30 K(-96.3%) | -$1.55 M(+1.7%) |
| Sept 2012 | - | -$1.04 M(+357.3%) | -$1.52 M(+155.1%) |
| June 2012 | - | -$227.20 K(-7.6%) | -$597.80 K(+71.4%) |
| Mar 2012 | - | -$245.80 K(+1805.4%) | -$348.70 K(+17.4%) |
| Dec 2011 | -$296.90 K | -$12.90 K(-88.5%) | -$296.90 K(-7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | -$111.90 K(-611.0%) | -$319.30 K(+54.0%) |
| June 2011 | - | $21.90 K(-111.3%) | -$207.40 K(-9.6%) |
| Mar 2011 | - | -$194.00 K(+449.6%) | -$229.30 K(+549.6%) |
| Dec 2010 | -$35.30 K(<-9900.0%) | -$35.30 K(<-9900.0%) | -$35.30 K(<-9900.0%) |
| Sept 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2009 | - | $0.00(0.0%) | -$1800.00(0.0%) |
| June 2009 | - | $0.00(-100.0%) | -$1800.00(-94.5%) |
| Dec 2008 | -$33.00 K(-87.1%) | -$1800.00(<-9900.0%) | -$33.00 K(-76.2%) |
| Sept 2008 | - | $0.00(-100.0%) | -$138.80 K(-20.2%) |
| June 2008 | - | -$22.30 K(+150.6%) | -$174.00 K(-14.3%) |
| Mar 2008 | - | -$8900.00(-91.7%) | -$203.10 K(-20.5%) |
| Dec 2007 | -$255.40 K(-58.7%) | -$107.60 K(+205.7%) | -$255.40 K(+65.4%) |
| Sept 2007 | - | -$35.20 K(-31.5%) | -$154.40 K(-42.1%) |
| June 2007 | - | -$51.40 K(-16.0%) | -$266.50 K(-42.4%) |
| Mar 2007 | - | -$61.20 K(+827.3%) | -$462.70 K(-25.3%) |
| Dec 2006 | -$619.10 K(+139.1%) | -$6600.00(-95.5%) | -$619.10 K(-22.0%) |
| Sept 2006 | - | -$147.30 K(-40.5%) | -$793.90 K(+22.6%) |
| June 2006 | - | -$247.60 K(+13.8%) | -$647.80 K(+44.5%) |
| Mar 2006 | - | -$217.60 K(+20.0%) | -$448.20 K(+73.1%) |
| Dec 2005 | -$258.90 K(-36.2%) | -$181.40 K(>+9900.0%) | -$259.00 K(+233.8%) |
| Sept 2005 | - | -$1200.00(-97.5%) | -$77.60 K(+1.6%) |
| June 2005 | - | -$48.00 K(+69.0%) | -$76.40 K(+169.0%) |
| Mar 2005 | - | -$28.40 K(<-9900.0%) | -$28.40 K(<-9900.0%) |
| Dec 2004 | -$405.70 K(<-9900.0%) | - | - |
| Mar 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2003 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| June 2003 | - | $0.00(0.0%) | $4800.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) | $4800.00(0.0%) |
| Dec 2002 | - | $0.00(-100.0%) | $4800.00(0.0%) |
| Sept 2002 | $4800.00(-25.0%) | $4800.00(>+9900.0%) | $4800.00(+2300.0%) |
| June 2002 | - | $0.00(-100.0%) | $200.00(-96.8%) |
| Sept 2001 | $6400.00(-112.4%) | $200.00(-94.7%) | $6300.00(+34.0%) |
| June 2001 | - | $3800.00(+123.5%) | $4700.00(-113.8%) |
| Mar 2001 | - | $1700.00(+183.3%) | -$34.10 K(-6.8%) |
| Dec 2000 | - | $600.00(-142.9%) | -$36.60 K(-28.9%) |
| Sept 2000 | -$51.50 K(+2045.8%) | -$1400.00(-96.0%) | -$51.50 K(-86.8%) |
| June 2000 | - | -$35.00 K(+4275.0%) | -$388.90 K(+3951.0%) |
| Mar 2000 | - | -$800.00(-94.4%) | -$9600.00(+3.2%) |
| Dec 1999 | - | -$14.30 K(-95.8%) | -$9300.00(+287.5%) |
| Sept 1999 | -$2400.00 | -$338.80 K(-198.4%) | -$2400.00(-100.7%) |
| June 1999 | - | $344.30 K(<-9900.0%) | $336.40 K(-4358.2%) |
| Mar 1999 | - | -$500.00(-93.2%) | -$7900.00(+6.8%) |
| Dec 1998 | - | -$7400.00 | -$7400.00 |
FAQ
- What is Acer Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Acer Therapeutics?
- What is Acer Therapeutics annual CFI year-on-year change?
- What is Acer Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Acer Therapeutics?
- What is Acer Therapeutics quarterly CFI year-on-year change?
- What is Acer Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Acer Therapeutics?
- What is Acer Therapeutics TTM CFI year-on-year change?
What is Acer Therapeutics annual cash flow from investing activities?
The current annual CFI of ACER is -$171.20 K
What is the all time high annual CFI for Acer Therapeutics?
Acer Therapeutics all-time high annual cash flow from investing activities is $967.30 K
What is Acer Therapeutics annual CFI year-on-year change?
Over the past year, ACER annual cash flow from investing activities has changed by -$116.30 K (-211.84%)
What is Acer Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ACER is $0.00
What is the all time high quarterly CFI for Acer Therapeutics?
Acer Therapeutics all-time high quarterly cash flow from investing activities is $977.60 K
What is Acer Therapeutics quarterly CFI year-on-year change?
Over the past year, ACER quarterly cash flow from investing activities has changed by +$2000.00 (+100.00%)
What is Acer Therapeutics TTM cash flow from investing activities?
The current TTM CFI of ACER is -$143.30 K
What is the all time high TTM CFI for Acer Therapeutics?
Acer Therapeutics all-time high TTM cash flow from investing activities is $1.03 M
What is Acer Therapeutics TTM CFI year-on-year change?
Over the past year, ACER TTM cash flow from investing activities has changed by -$72.70 K (-102.97%)